Dr. Alyssa Bautista, MD

Dr. Bautista practices at Columbia University Irving Medical Center in New York, New York.

Dr. Bautista's NPI, 1588073969, was assigned on August 11, 2014. Dr. Bautista graduated from University of Santo Tomas in 2010. Dr. Bautista holds New York license 299836.

Dr. Bautista's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Bautista's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Bautista is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Bautista to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bautista practices. Vendor and product names are available with a free account.

Neurology is Dr. Bautista's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bautista is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bautista's licenses on file in 2 states: New York and California.

Dmand AI lists mini-stroke (TIA), seizures, stroke and traumatic coma among the conditions Dr. Bautista treats.

CMS data shows 437 Medicare services from Dr. Bautista across 7 procedure codes in 2024, for 279 Medicare patients. Medicare paid $53,774 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 279 Medicare patients who saw Dr. Bautista in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bautista's median patient age at 71, with 54% women.

In 2022, Dr. Bautista wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $78 in total drug cost. In 2016, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bautista for performance year 2024, reported through an alternative payment model (APM). Dr. Bautista accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bautista as offering telehealth.

Dmand AI links 3 papers to Dr. Bautista, published from 2019 to 2021. The most frequent topics are COVID-19 and SARS-CoV-2. Dr. Bautista's most frequent co-authors are Jan Claassen, MD, Kiran Teresa Thakur, MD and Imo Joseph Akpan, MD.

CMS Open Payments shows 13 general payments to Dr. Bautista from 7 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Portola Pharmaceuticals, LLC paid the most, $261.

Dr. Bautista graduated from University of Santo Tomas in 2010.

Dr. Bautista is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.